Literature DB >> 9622300

Multiple endocrine neoplasia type 1 is not rare in Japan.

M Katai1, A Sakurai, Y Itakura, Y Ikeo, K Nakajima, M Hara, S Iijima, T Kaneko, M Kobayashi, K Ichikawa, T Aizawa, K Hashizume.   

Abstract

Multiple endocrine neoplasia type 1 (MEN 1) is rarely reported in Japanese and other oriental populations. To examine if there is a racial difference in the prevalence of MEN 1, we initiated extensive work on patients with endocrine tumors for additional lesions, and annual screening of family members of affected patients. In a four-year study, eleven asymptomatic patients were found by family screening, and the number of patients with MEN 1 in our clinics increased from 16 to 38. Estimated prevalence of MEN 1 was no less than 0.018/1000. MEN 1 may not be as rare as had been thought in Japanese, and the prevalence of MEN 1 in Japanese would not be significantly different from that of Caucasians. Systemic surveillance and extensive screening of family members are required for early detection and management of patients.

Entities:  

Mesh:

Year:  1997        PMID: 9622300     DOI: 10.1507/endocrj.44.841

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  2 in total

1.  VIPoma with multiple endocrine neoplasia type 1 identified as an atypical gene mutation.

Authors:  Atsushi Fujiya; Makoto Kato; Taiga Shibata; Hiroshi Sobajima
Journal:  BMJ Case Rep       Date:  2015-11-12

2.  Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.

Authors:  Akihiro Sakurai; Miyuki Katai; Wataru Yumita; Kesami Minemura; Kiyoshi Hashizume
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.